NCT05462873 2026-02-17A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid TumorsNovartisPhase 1 Terminated30 enrolled
NCT06560645 2026-02-02A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationPrelude TherapeuticsPhase 1 Terminated42 enrolled